Keyword search (4,163 papers available)

"He M" Authored Publications:

Title Authors PubMed ID
1 Segregation of competing voices by their fundamental frequency relies on low-frequency regions Calinescu C; Deroche M; 41817225
PSYCHOLOGY
2 Psychophysical evidence of the harmonic cancellation process and its relationship to pitch sensitivity and voice segregation Deroche M; Montagnese J; Khoury K; Iuliano R; Alemi R; 41263633
PSYCHOLOGY
3 Reduced Eye Blinking During Sentence Listening Reflects Increased Cognitive Load in Challenging Auditory Conditions Coupal P; Zhang Y; Deroche M; 40910460
PSYCHOLOGY
4 Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry Schebb NH; Kampschulte N; Hagn G; Plitzko K; Meckelmann SW; Ghosh S; Joshi R; Kuligowski J; Vuckovic D; Botana MT; Sánchez-Illana Á; Zandkarimi F; Das A; Yang J; Schmidt L; Checa A; Roche HM; Armando AM; Edin ML; Lih FB; Aristizabal-Henao JJ; Miyamoto S; Giuffrida F; Moussaieff A; Domingues R; Rothe M; Hinz C; Das US; Rund KM; Taha AY; Hofstetter RK; Werner M; Werz O; Kahnt AS; Bertrand-Michel J; Le Faouder P; Gurke R; Thomas D; Torta F; Milic I; Dias IHK; Spickett CM; Biagini D; Lomonaco T; Idborg H; Liu J 40392938
CHEMBIOCHEM
5 Pupillometry reveals effects of pitch manipulation within and across words on listening effort and short-term memory Zhang Y; Sares A; Delage A; Lehmann A; Deroche M; 39349635
CONCORDIA
6 Differences Between French and English in the Use of Suprasegmental Cues for the Short-Term Recall of Word Lists Lew EC; Sares A; Gilbert AC; Zhang Y; Lehmann A; Deroche M; 39320319
PSYCHOLOGY
7 The role of language in ethnic identity measurement: a multitrait-multimethod approach to construct validation Laroche M; Pons F; Richard MO; 19702108
JMSB
8 OFC neurons do not represent the negative value of a conditioned inhibitor Esber GR; Usypchuk A; Saini S; Deroche M; Iordanova MD; Schoenbaum G; 38042330
CONCORDIA
9 Audiovisual integration in children with cochlear implants revealed through EEG and fNIRS Alemi R; Wolfe J; Neumann S; Manning J; Towler W; Koirala N; Gracco VL; Deroche M; 37989460
PSYCHOLOGY
10 Motor Processing in Children With Cochlear Implants as Assessed by Functional Near-Infrared Spectroscopy Alemi R; Wolfe J; Neumann S; Manning J; Hanna L; Towler W; Wilson C; Bien A; Miller S; Schafer E; Gemignani J; Koirala N; Gracco VL; Deroche M; 37977135
PSYCHOLOGY
11 Factors Associated with Speech-Recognition Performance in School-Aged Children with Cochlear Implants and Early Auditory-Verbal Intervention Wolfe J; Deroche M; Neumann S; Hanna L; Towler W; Wilson C; Bien AG; Miller S; Schafer EC; Gracco V; 34847584
PSYCHOLOGY
12 Flame-Retardant and Polysulfide-Suppressed Ether-Based Electrolytes for High-Temperature Li-S Batteries He M; Li X; Holmes NG; Li R; Wang J; Yin G; Zuo P; Sun X; 34370436
ENCS
13 A Cross-Sectional Study on the Impact of Arterial Stiffness on the Corpus Callosum, a Key White Matter Tract Implicated in Alzheimer's Disease Badji A; de la Colina AN; Boshkovski T; Sabra D; Karakuzu A; Robitaille-Grou MC; Gros C; Joubert S; Bherer L; Lamarre-Cliche M; Stikov N; Gauthier CJ; Cohen-Adad J; Girouard H; 32741837
PERFORM
14 Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Fortuné C, Gietzen A, Guillot G, Lewis N, Nielsen K, Richard M, Sauvé M, Welling J, SPIN Investigators, Baron M, Furst DE, Gottesman K, Malcarne V, Mayes MD, Mouthon L, Nielson WR, Riggs R, Wigley F, Assassi S, Boutron I, Ells C, van den Ende C, Fligelstone K, Frech T, Godard D, Harel D, Hinchcliff M, Hudson M, Johnson SR, Larche M, Leite C, Nguyen C, Pope J, Portales A, Rannou F, Reyna TSR, Schouffoer AA, Suarez-Almazor ME, Agard C, Albert A, André M, Arsenault G, Benzidia I, Bernstein EJ, Berthier S, Biss 32419703
PSYCHOLOGY
15 Association Between Paraspinal Muscle Morphology, Clinical Symptoms, and Functional Status in Patients With Degenerative Cervical Myelopathy. Fortin M, Dobrescu O, Courtemanche M, Sparrey CJ, Santaguida C, Fehlings MG, Weber MH 28207658
PERFORM
16 Enzymatic assay for GHB determination in forensic matrices. Grenier V, Huppé G, Lamarche M, Mireault P 22722059
MASSSPEC
17 Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Laroc 27118291
HKAP
18 Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell 28449828
HKAP
19 Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, 29731013
NA

 

Title:Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Authors:Leung AANerenberg KDaskalopoulou SSMcBrien KZarnke KBDasgupta KCloutier LGelfer MLamarre-Cliche MMilot ABolli PTremblay GMcLean DTobe SWRuzicka MBurns KDVallée MPrasad GVLebel MFeldman RDSelby PPipe ASchiffrin ELMcFarlane PAOh PHegele RAKhara MWilson TWPenner SBBurgess EHerman RJBacon SLRabkin SWGilbert RECampbell TSGrover SHonos GLindsay PHill MDCoutts SBGubitz GCampbell NRMoe GWHowlett JGBoulanger JMPrebtani ALaroc
Link:https://www.ncbi.nlm.nih.gov/pubmed/27118291?dopt=Abstract
Publication:
Keywords:
PMID:27118291 Category:Can J Cardiol Date Added:2019-05-31
Dept Affiliation: HKAP
1 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: aacleung@ucalgary.ca.
2 Department of Medicine and Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada.
3 Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Quebec, Canada.
4 Departments of Family Medicine and Community Health Sciences, Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
5 Division of General Internal Medicine, University of Calgary, Calgary, Alberta, Canada.
6 Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada.
7 Department of Family Medicine, University of British Columbia, Copeman Healthcare Centre, Vancouver, British Columbia, Canada.
8 Institut de Recherches Cliniques de Montréal, Université de Montréal, Montréal, Quebec, Canada.
9 Department of Medicine, Université Laval, Québec, Quebec, Canada.
10 Ambulatory Internal Medicine Teaching Clinic, St Catharines, Ontario, Canada.
11 CHU-Québec-Hopital St Sacrement, Québec, Quebec, Canada.
12 University of Alberta, Edmonton, Alberta, Canada.
13 University of Toronto, Toronto, Ontario, Canada.
14 Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
15 Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Quebec, Canada.
16 Discipline of Medicine, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
17 Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
18 University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
19 Department of Medicine and Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
20 Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
21 University Health Network, University of Toronto, Toronto, Ontario, Canada.
22 Departments of Medicine (Division of Endocrinology) and Biochemistry, Western University, London, Ontario, Canada.
23 Vancouver Coastal Health Addiction Services, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
24 Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
25 Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
26 Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
27 Department of Exercise Science, Concordia University, and Montreal Behavioural Medicine Centre, Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada.
28 Vancouver Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
29 Division of Endocrinology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
30 Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
31 Division of Clinical Epidemiology, Montreal General Hospital, Montreal, Quebec, Canada.
32 University of Montreal, Montreal, Quebec, Canada.
33 Best Practices and Performance, Heart and Stroke F

Description:

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Can J Cardiol. 2016 05;32(5):569-88

Authors: Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM, CHEP Guidelines Task Force

Abstract

Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 new recommendations, as well as revisions to 2 previous recommendations. In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure. Also, although a serum lipid panel remains part of the routine laboratory testing for patients with hypertension, fasting and nonfasting collections are now considered acceptable. For individuals with secondary hypertension arising from primary hyperaldosteronism, adrenal vein sampling is recommended for those who are candidates for potential adrenalectomy. With respect to the treatment of hypertension, a new recommendation that has been added is for increasing dietary potassium to reduce blood pressure in those who are not at high risk for hyperkalemia. Furthermore, in selected high-risk patients, intensive blood pressure reduction to a target systolic blood pressure = 120 mm Hg should be considered to decrease the risk of cardiovascular events. Finally, in hypertensive individuals with uncomplicated, stable angina pectoris, either a ß-blocker or calcium channel blocker may be considered for initial therapy. The specific evidence and rationale underlying each of these recommendations are discussed. Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force will continue to provide annual updates.

PMID: 27118291 [PubMed - indexed for MEDLINE]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University